Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Endokrinologiis Erovnul… | Curatio | Med Investment | Reimani | Adiktologiis Regionalur… |
|---|---|---|---|---|---|
| Total Revenue | 15,944 | 14,553 | 14,149 | 11,511 | — |
| Total COGS | -2,048 | -429 | 0 | -8,176 | — |
| Gross Profit | 13,896 | 14,124 | 14,149 | 3,335 | — |
| Gross Margin | 87.2% | 97.1% | 100.0% | 29.0% | — |
| Total Operating Expenses | -11,780 | -11,686 | -13,285 | -4,810 | — |
| EBITDA | 2,116 | 2,438 | 864 | -1,475 | — |
| EBITDA Margin | 13.3% | 16.8% | 6.1% | -12.8% | — |
| Total D&A | -335 | -441 | -485 | -206 | — |
| EBIT / Operating Income | 1,781 | 1,997 | 379 | -1,681 | — |
| Total Interest Expense | -142 | -838 | -88 | -1,130 | — |
| Total Other Income | 13 | 13 | -89 | -205 | — |
| Profit Before Tax | 1,652 | 1,171 | 316 | -3,015 | — |
| Total Income Tax | -162 | -5 | 0 | 0 | — |
| Net Profit / (Loss) | 1,490 | 1,166 | 756 | -1,737 | — |
| Net Margin | 9.3% | 8.0% | 5.3% | -15.1% | — |
| Total Interest Income | — | — | 114 | — | — |
Not every picked company reports every selected year — FY2024: no filing for Adiktologiis Regionalur…. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Curatio | Healthcare Services | 16.8% | 71st pct | 268 |
| Endokrinologiis Erovnul… | Healthcare Services | 13.3% | 59th pct | 268 |
| Med Investment | Healthcare Services | 6.1% | 38th pct | 268 |
| Reimani | Healthcare Services | -12.8% | 12th pct | 268 |
| Adiktologiis Regionalur… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.